Skip to main content
Premium Trial:

Request an Annual Quote

SurroMed and InterMune Start Biomarker Collaboration

NEW YORK, March 4 - SurroMed and InterMune are collaborating to discover new biomarkers, the companies said today.

 

SurroMed will analyze clinical samples provided by InterMune using its mass spectrometry-based technology.

 

InterMune hopes new biomarkers will help it better understand drug responses in ongoing clinical trials as well as find new drugs for pulmonary and hepatic disease.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.